Loading…
Loading grant details…
| Funder | Wellcome Trust |
|---|---|
| Recipient Organization | University of Edinburgh |
| Country | United Kingdom |
| Start Date | Aug 05, 2023 |
| End Date | Aug 04, 2031 |
| Duration | 2,921 days |
| Number of Grantees | 1 |
| Roles | Award Holder |
| Data Source | Europe PMC |
| Grant ID | 227287 |
Astrocytes are a highly abundant cell type in the central nervous system. They perform critical homeostatic functions but respond to insults by undergoing a ‘reactive transformation’.
By applying integrative single cell RNA-seq and genome-wide spatial transcriptomics I have recently discovered that astrocytes fall into discrete subtypes that occupy distinct spaces in the brain, and that each subtype undergoes a subtype-specific reactive transformation during brain inflammation.
Key goals of my project are understanding how homeostatic, regionally-restricted astrocyte subtypes turn into specialized reactive subtypes in neuroinflammation and chronic neurodegeneration, particularly Alzheimer’s disease (AD).
I have already identified two subtypes relevant to neurodegeneration: 1 – An astrocyte ‘super-responder’ subtype that is induced by type-I-interferons and is selectively present around amyloid plaque depositions. 2 – I identified the transcriptomic identity of glia limitans superficialis astrocytes that cover the entire brain and spinal cord surface and can be described by a single gene, Myoc.
Using scRNA-seq, spatial transcriptomics, advanced bioinformatic analyses as well as novel and established astrocyte-specific transgenic mice combined with functional in vitro assays, I will uncover the upstream-inducers and downstream functions of specialized astrocyte subtypes in order to identify novel therapeutic targets in neurodegeneration and neuroinflammation.
University of Edinburgh
Complete our application form to express your interest and we'll guide you through the process.
Apply for This Grant